Axa’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-146,371
| Closed | -$672K | – | 1284 |
|
|
2019
Q4 | $672K | Sell |
146,371
-171,905
| -54% | -$789K | ﹤0.01% | 948 |
|
|
2019
Q3 | $1.23M | Sell |
318,276
-242,845
| -43% | -$941K | ﹤0.01% | 954 |
|
|
2019
Q2 | $3.38M | Sell |
561,121
-13,799
| -2% | -$83.2K | 0.01% | 753 |
|
|
2019
Q1 | $7.7M | Buy |
574,920
+208,543
| +57% | +$2.79M | 0.03% | 527 |
|
|
2018
Q4 | $3.41M | Buy |
+366,377
| New | +$3.41M | 0.01% | 699 |
|
|
2018
Q2 | – | Sell |
-220,413
| Closed | -$3.79M | – | 1434 |
|
|
2018
Q1 | $3.79M | Buy |
220,413
+87,548
| +66% | +$1.5M | 0.02% | 724 |
|
|
2017
Q4 | $2.91M | Sell |
132,865
-138
| -0.1% | -$3.03K | 0.01% | 781 |
|
|
2017
Q3 | $5.44M | Buy |
+133,003
| New | +$5.44M | 0.02% | 606 |
|
|
2017
Q2 | – | Sell |
-15,400
| Closed | -$557K | – | 1325 |
|
|
2017
Q1 | $557K | Buy |
15,400
+6,700
| +77% | +$242K | ﹤0.01% | 1055 |
|
|
2016
Q4 | $436K | Sell |
8,700
-39,900
| -82% | -$2M | ﹤0.01% | 1079 |
|
|
2016
Q3 | $2.55M | Sell |
48,600
-6,200
| -11% | -$325K | 0.01% | 701 |
|
|
2016
Q2 | $2.27M | Buy |
+54,800
| New | +$2.27M | 0.01% | 720 |
|